Advertisement
Advertisement

OSTX

OSTX logo

OS Therapies Inc

4.08
USD
-0.63
-13.38%
Dec 18, 15:59 UTC -5
Closed
...

OS Therapies Inc Profile

About

OS Therapies Incorporated is a clinical stage oncology company focused on the identification, development and commercialization of treatments for Osteosarcoma and other solid tumors. The company's lead asset consists OST-HER2. OS Therapies Incorporated is based in NEW YORK.

Info & Links

CEO

Paul A.Romness

Headquarters

15825 SHADY GROVE ROAD, SUITE 135
ROCKVILLE, MD 20850, UNITED STATES

Auditor

Share holders

--

Employees

--

OS Therapies Inc Statistics

Valuation Measures

Market Capitalization2

86.66M

Enterprise Value

84.80M

Enterprise Value/EBITDA(ttm)

-25.21

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

424.18%

Return on Assets(ttm)

-569.57%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-3.36M

Net Income Available to Common(ttm)

-7.42M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

21.24M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

1.86M

Total Cash Per Share(mrq)

0.09

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.76%

Quick Ratio(mrq)

0.76%

Book Value Per Share(mrq)

-0.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.31

Free Cash Flow(ytd)

-4.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement